Okea ASA (OKEA)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 45.80 |
|---|---|
| 52-week range | 17.36 – 47.80 |
| Return, 1 month / 3 months | +15.5% / +30.9% |
| Return, 1 year / 3 years | +151.6% / +19.7% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 44.6% |
| Worst drawdown (1 year) | -32.9% |
| Average daily value traded | 11.84M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Okea is a Norwegian oil and gas company that explores for, develops and produces hydrocarbons on the Norwegian Continental Shelf. It operates the Draugen field and holds interests in other producing assets, including Gjoea and Ivar Aasen. Its customers are the buyers of its crude oil and natural gas, and the company is based in Trondheim, Norway. Okea focuses on mature fields and near-field exploration and production opportunities.
The shares are listed on the Oslo Stock Exchange in Norway under the code OKEA, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Okea ASA (OKEA) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 45.80 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 33 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 151.6% and over the last three months it rose 30.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 30.5% | ||
| From 52-week high | -3.6% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 30.9% | ||
| 6-month return | 17.6% | ||
| 12-month return, skipping the last month | 117.9% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.9% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 11.84M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | +15.5% |
| 3 months | +30.9% |
| 6 months | +17.6% |
| 1 year | +151.6% |
| 3 years | +19.7% |
| 5 years | +85.6% |
Signals
| 50-day / 200-day average | 40.61 / 35.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Dec 2023 | NOK 1.0000 |
| 1 Sep 2023 | NOK 1.0000 |
| 2 Jun 2023 | NOK 1.0000 |
| 2 Mar 2023 | NOK 1.0000 |
| 2 Dec 2022 | NOK 1.0000 |
| 2 Sep 2022 | NOK 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.